dihydroxyphenylalanine has been researched along with Carcinoma, Oat Cell in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacob, T | 1 |
| Grahek, D | 1 |
| Younsi, N | 1 |
| Kerrou, K | 1 |
| Aide, N | 1 |
| Montravers, F | 1 |
| Balogova, S | 1 |
| Colombet, C | 1 |
| De Beco, V | 1 |
| Talbot, JN | 1 |
1 trial available for dihydroxyphenylalanine and Carcinoma, Oat Cell
| Article | Year |
|---|---|
Positron emission tomography with [(18)F]FDOPA and [(18)F]FDG in the imaging of small cell lung carcinoma: preliminary results.
Topics: Adult; Aged; Carcinoma, Small Cell; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; | 2003 |